Anzeige
Mehr »
Login
Freitag, 17.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 924447 | ISIN: US7495521053 | Ticker-Symbol: RF5
Frankfurt
16.01.25
08:02 Uhr
3,860 Euro
+0,340
+9,66 %
Branche
Elektrotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
RF INDUSTRIES LTD Chart 1 Jahr
5-Tage-Chart
RF INDUSTRIES LTD 5-Tage-Chart
RealtimeGeldBriefZeit
3,9404,06016.01.
ACCESSWIRE
192 Leser
Artikel bewerten:
(1)

RF Industries, Ltd.: RF Industries Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Finanznachrichten News

SAN DIEGO, CA / ACCESS Newswire / January 16, 2025 / RF Industries, Ltd, (NASDAQ:RFIL), a national manufacturer and marketer of interconnect products and systems, today announced fourth quarter and fiscal year 2024 financial results for the fiscal year ended October 31, 2024.

Fourth Quarter Fiscal 2024 Highlights and Operating Results:

  • Net sales were $18.5 million; an increase of 16% from $15.9 million year-over-year and a 10% increase from $16.8 million in the third fiscal quarter

  • Backlog of $19.5 million at year-end on fourth quarter bookings of $17.9 million. As of today, the backlog stands at $14.9 million

  • Gross profit margin was 31.3% up from 28.4% in the prior year quarter

  • Operating income was $96,000, an improvement from the operating loss of $1.1 million year-over-year

  • Consolidated net loss was $238,000, or $0.02 per diluted share, an improvement from a consolidated net loss of $851,000, or $0.08 per diluted share year-over-year

  • Non-GAAP net income was $394,000, or $0.04 per diluted share, compared to a non-GAAP net loss of $434,000, or $0.04 per diluted share in the fourth quarter of fiscal 2023

  • Adjusted EBITDA was $908,000, up from an Adjusted EBITDA loss of $108,000 year-over-year

Fiscal 2024 Highlights and Operating Results:

  • Net sales were $64.9 million, a decrease of 10% from $72.2 million year-over-year

  • Gross profit margin was 29.1%, an improvement of 200 basis points from 27.1% for fiscal year 2023

  • Operating loss was $2.8 million, an improvement from an operating loss of $3.8 million in fiscal 2023

  • Adjusted EBITDA was $838,000, up from $460,000 in the prior-year period

  • Cash and cash equivalents at year end were $839,000

  • Inventory decreased 21% year-over-year through designed improvements to procurement and supply chain processes

See "Note Regarding Use of Non-GAAP Financial Measures," "Unaudited Reconciliation of GAAP to non-GAAP Net Income" and "Unaudited Reconciliation of Net Income to Adjusted EBITDA" below for additional information.

Management Commentary

"Our team put us on solid ground at year end by delivering improving performance throughout a challenging market environment in fiscal year 2024. Fourth quarter net sales increased 16% to $18.5 million, our gross profit margin improved 290 basis points to 31.3%, from 28.4% in the prior year, Adjusted EBITDA was $908,000, and we achieved an operating profit for the first time since the second quarter of fiscal year 2023, underscoring our heavy focus on driving profitability. We ended the year with a strong balance sheet after paying down our debt to $8.2 million versus $14.1 million at the end of last fiscal year," said Robert Dawson, Chief Executive Officer of RF Industries.

"We did a lot of heavy lifting during the cyclical downturn to strategically position our business for a rebound. We believe in our overall strategy, and we stayed the course even through a challenging timeframe. This focus helped accelerate our ongoing transformation into a full solutions provider that has both a strong interconnect product offering and turnkey solutions for key applications in small cells, distributed antenna systems (DAS), industrial connectivity, and DAC thermal cooling. Today, we believe we have the right products and solutions, the right customer relationships and the right positioning within organizations. We bolstered our sales team with experienced talent who we expect will help us effectively penetrate our target markets, and we did this without increasing overall expense."

"For fiscal year 2025, sales growth is a high priority, but we are also laser focused on profit improvement and pushing toward our goal of at least 10% Adjusted EBITDA margin. To accomplish this, we are taking a disruptive approach to the overall structure of our production and fulfilment operations. Over the next several quarters, we expect a completely redesigned operations infrastructure that will give us a competitive edge in the market-allow us to scale more quickly-and deliver sustainable profitability. We have a goal of achieving 10% Adjusted EBITDA or greater, and our team is fully engaged on the best ways to get there."

"We are starting to see momentum, and even with some challenging market conditions still in the picture, we have more clarity going forward than we did at the end of fiscal year 2023. While the fiscal first quarter has typically been seasonally our most challenging, we anticipate that net sales will be roughly in line with our fourth quarter revenue of $18.5 million, a significant improvement over last year's first quarter revenue of $13.5 million. I am extremely proud and appreciative of the RFI team's hard work and efforts to identify new growth opportunities, and we are determined to generate additional momentum throughout fiscal 2025 and deliver on our financial goals that will create sustainable long-term value for our stakeholders," concluded Dawson.

Conference Call and Webcast

RF Industries will host a conference call and live webcast today, January 16, 2025, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its fiscal fourth quarter and full year 2024 financial results. To access the live call, dial 888-506-0062 (US and Canada) or 973-528-0011 (International) and give the participant access code 331321.

About RF Industries

RF Industries designs and manufactures a broad range of interconnect products across diversified, growing markets, including wireless/wireline telecom, data communications and industrial. The Company's products include high-performance components used in commercial applications such as RF connectors and adapters, RF passives including dividers, directional couplers and filters, coaxial cables, data cables, wire harnesses, fiber optic cables, custom cabling, energy-efficient cooling systems and integrated small cell enclosures. The Company is headquartered in San Diego, California with additional operations in New York, Connecticut, Rhode Island and New Jersey. Please visit the RF Industries website at www.rfindustries.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, with respect to future events. Forward-looking statements include, among others, statements concerning our expectations about profitability, revenues, industry trends, markets and demand for our products, backlog, financial goals, growth opportunities and the expected benefits and desirability of our products, in each case which are subject to a number of factors that could cause actual results to differ materially. Factors that could cause or contribute to such differences include, but are not limited to: the Company's cash and liquidity needs, ability to continue as a going concern, non-compliance with terms and covenants in our credit facility, changes in the telecommunications industry and materialization and timing of expected network buildouts; timing and breadth of new products; our ability to realize increased sales; successfully integrating new products and teams; our ability to execute on its go-to-market strategies and channel models; our reliance on certain distributors and customers for a significant portion of anticipated revenues; the impact of existing and additional future tariffs imposed by U.S. and foreign nations; our ability to expand our OEM relationships; our ability to continue to deliver newly designed and custom fiber optic and cabling products to principal customers; our ability to maintain strong margins and diversify our customer base; our ability to initiate operating efficiencies, cost savings and expense reductions; our ability to address the changing needs of the market and capitalize on new market opportunities; our ability to add value to our customer's needs; the success of any product launches; and our ability to increase revenue, gross margins or obtain profitability in a timely manner. Further discussion of these and other potential risks and uncertainties may be found in the Company's public filings with the Securities and Exchange Commission (www.sec.gov) including our Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. All forward-looking statements are based upon information available to the Company on the date they are published, and we undertake no obligation to publicly update or revise any forward-looking statements to reflect events or new information after the date of this release.

Note Regarding Use of Non-GAAP Financial Measures

To supplement our unaudited condensed financial statements presented in accordance with U.S. generally accepted accounting principles (GAAP), this earnings release and the accompanying tables and the related earnings conference call contain certain non-GAAP financial measures, including adjusted earnings before interest, taxes, depreciation, amortization (Adjusted EBITDA), non-GAAP net income, non-GAAP net loss and non-GAAP earnings per share, basic and diluted (non-GAAP EPS).

We believe these financial measures provide useful information to investors with which to analyze our operating trends and performance by excluding certain non-cash and other one-time expenses that we believe are not indicative of our operating results.

In computing Adjusted EBITDA, non-GAAP net income, non-GAAP net loss and non-GAAP EPS, we exclude stock-based compensation expense, which represents non-cash charges for the fair value of stock options and other non-cash awards granted to employees, non-cash and other lease charges, and severance. For Adjusted EBITDA, we also exclude depreciation, amortization, interest expense and provision for income taxes. Because of varying available valuation methodologies, subjective assumptions, and the variety of equity instruments that can impact a company's non-cash operating expenses, we believe that providing non-GAAP financial measures that exclude non-cash expense and non-recurring costs and expenses allows for meaningful comparisons between our core business operating results and those of other companies, as well as providing us with an important tool for financial and operational decision-making and for evaluating our own core business operating results over different periods of time.

Our Adjusted EBITDA, non-GAAP net income, non-GAAP net loss and non-GAAP EPS measures may not provide information that is directly comparable to that provided by other companies in our industry, as other companies in our industry may calculate non-GAAP financial results differently, particularly related to non-recurring, unusual items. Our Adjusted EBITDA, non-GAAP net income, non-GAAP net loss and non-GAAP EPS are not measurements of financial performance under GAAP and should not be considered as an alternative to operating or net income or as an indication of operating performance or any other measure of performance derived in accordance with GAAP. We do not consider these non-GAAP measures to be a substitute for, or superior to, the information provided by GAAP financial results. Non-GAAP financial measures are subject to limitations and should be read only in conjunction with the Company's consolidated financial statements prepared in accordance with GAAP. We believe that these non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our GAAP results of operations. We compensate for the limitations of non-GAAP financial measures by relying upon GAAP results to gain a complete picture of our performance. A reconciliation of specific adjustments to GAAP results is provided in the last two tables at the end of this press release.

In addition, we have included order bookings and backlogs in this earnings release. Bookings represent new orders that have been received inclusive of any modification or cancellation of previous orders. Backlog represents orders that have been received where revenue has not been recognized as of the specified date. We believe both Bookings and Backlog are indicators of future revenues that the Company expects to generate based on orders that management believes to be firm.

RF Industries Contact:

Peter Yin

SVP and CFO

(858) 549-6340

rfi@rfindustries.com

IR Contact:

Margaret Boyce

Financial Profiles, Inc.

(310) 622-8247

RFIL@finprofiles.com

RF INDUSTRIES, LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)

Oct. 31,

Oct. 31,

2024

2023

ASSETS

(unaudited)

(audited)

CURRENT ASSETS

Cash and cash equivalents

$

839

$

4,897

Trade accounts receivable, net

12,119

10,277

Inventories

14,725

18,730

Other current assets

1,430

2,136

TOTAL CURRENT ASSETS

29,113

36,040

Property and equipment, net

4,813

4,924

Operating right of use asset, net

15,265

15,689

Goodwill

8,085

8,085

Amortizable intangible assets, net

11,908

13,595

Non-amortizable intangible assets

1,174

1,174

Deferred tax assets

-

2,494

Other assets

688

277

TOTAL ASSETS

$

71,046

$

82,278

LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES

Accounts payable and accrued expenses

$

8,045

$

7,773

Line of Credit

8,197

1,000

Current portion of Term Loan

-

2,424

Current portion of operating lease liabilities

1,848

1,314

TOTAL CURRENT LIABILITIES

18,090

12,511

Operating lease liabilities

18,680

19,284

Term Loan, net of debt issuance cost

-

10,721

Deferred tax liabilities

210

-

TOTAL LIABILITIES

36,980

42,516

COMMITMENTS AND CONTINGENCIES

STOCKHOLDERS' EQUITY

Common stock, authorized 20,000,000 shares of $0.01 par value;

10,544,431 and 10,343,223 shares issued and outstanding at

October 31, 2024 and October 31, 2023, respectively

106

104

Additional paid-in capital

26,988

26,087

Retained earnings

6,972

13,571

TOTAL STOCKHOLDERS' EQUITY

34,066

39,762

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$

71,046

$

82,278

RF INDUSTRIES, LTD. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share amounts)

Three Months Ended

Fiscal Year Ended

October 31,

October31,

2024

2023

2024

2023

(unaudited)

(unaudited)

(unaudited)

(unaudited)

Net sales

$

18,453

$

15,874

$

64,857

$

72,168

Cost of sales

12,670

11,368

45,986

52,631

Gross profit

5,783

4,506

18,871

19,537

Operating expenses:

Engineering

723

616

2,782

3,151

Selling and general

4,964

4,997

18,912

20,183

Total operating expenses

5,687

5,613

21,694

23,334

Operating income (loss)

96

(1,107

)

(2,823

)

(3,797

)

Other expense

(304

)

(110

)

(980

)

(453

)

Loss before provision (benefit) for income taxes

(208

)

(1,217

)

(3,803

)

(4,250

)

Provision (benefit) from income taxes

30

(366

)

2,796

(1,172

)

Consolidated net loss

$

(238

)

$

(851

)

$

(6,599

)

$

(3,078

)

Loss per share - Basic

$

(0.02

)

$

(0.08

)

$

(0.63

)

$

(0.30

)

Loss per share - Diluted

$

(0.02

)

$

(0.08

)

$

(0.63

)

$

(0.30

)

Weighted average shares outstanding:

Basic

10,526,429

10,330,325

10,481,835

10,283,449

Diluted

10,526,429

10,330,325

10,481,835

10,283,449

RF INDUSTRIES, LTD. AND SUBSIDIARIES
Unaudited Reconciliation of GAAP to Non-GAAP Net Loss
(In thousands, except share and per share amounts)

Three Months Ended

Fiscal Year Ended

October 31,

October 31,

2024

2023

2024

2023

Consolidated net loss

$

(238

)

$

(851

)

$

(6,599

)

$

(3,078

)

Provision (benefit) from income taxes

30

(366

)

2,796

(1,172

)

Stock-based compensation expense

180

211

924

898

Non-cash and other one-time charges

-

150

145

851

Severance

-

-

56

75

Amortization expense

422

422

1,688

1,701

Non-GAAP net income (loss)

$

394

$

(434

)

$

(990

)

$

(725

)

Non-GAAP earnings (loss) per share:

Basic

$

0.04

$

(0.04

)

$

(0.09

)

$

(0.07

)

Diluted

$

0.04

$

(0.04

)

$

(0.09

)

$

(0.07

)

Weighted average shares outstanding

Basic

10,526,429

10,330,325

10,481,835

10,283,449

Diluted

10,526,429

10,330,325

10,481,835

10,283,449

RF INDUSTRIES, LTD. AND SUBSIDIARIES
Unaudited Reconciliation of Net Loss to Adjusted EBITDA
(In thousands)

Three Months Ended

Fiscal Year Ended

October 31,

October 31,

2024

2023

2024

2023

Consolidated net loss

$

(238

)

$

(851

)

$

(6,599

)

$

(3,078

)

Stock-based compensation expense

180

211

924

898

Non-cash and other one-time charges

-

150

145

851

Severance

-

-

56

75

Amortization expense

422

422

1,688

1,701

Depreciation expense

210

216

848

732

Other expense

304

110

980

453

Provision (benefit) from income taxes

30

(366

)

2,796

(1,172

)

Adjusted EBITDA

$

908

$

(108

)

$

838

$

460

SOURCE: RF Industries, Ltd.



View the original press release on ACCESS Newswire

© 2025 ACCESSWIRE
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.